| 000 | 01383 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513200051.0 | ||
| 264 | 0 | _c19991222 | |
| 008 | 199912s 0 0 eng d | ||
| 022 | _a0735-7907 | ||
| 024 | 7 |
_a10.3109/07357909909032840 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStinson, T J | |
| 245 | 0 | 0 |
_aCost analysis of second-line therapies for platinum-refractory ovarian cancer: reimbursement dilemmas for Medicare patients. _h[electronic resource] |
| 260 |
_bCancer investigation _c1999 |
||
| 300 |
_a559-65 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xeconomics |
| 650 | 0 | 4 |
_aCisplatin _xtherapeutic use |
| 650 | 0 | 4 | _aCosts and Cost Analysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHealth Care Costs |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInsurance, Health, Reimbursement |
| 650 | 0 | 4 | _aManaged Care Programs |
| 650 | 0 | 4 |
_aMedicare _xeconomics |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdrug therapy |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aCalhoun, E | |
| 700 | 1 | _aYang, T | |
| 700 | 1 | _aLurain, J R | |
| 700 | 1 | _aBennett, C L | |
| 773 | 0 |
_tCancer investigation _gvol. 17 _gno. 8 _gp. 559-65 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/07357909909032840 _zAvailable from publisher's website |
| 999 |
_c10548898 _d10548898 |
||